ReCode Therapeutics Alternatives & Competitors
12 companies similar to ReCode Therapeutics — Powering the next wave of genetic medicines through superior delivery
Companies similar to ReCode Therapeutics
BreezeBio
Genetic Medicine Delivered
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
AusperBio
Transforming Patient Lives For a Better Tomorrow
Rival Readout
Competing with ReCode Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
RIGImmune Inc.
Targeted non-LNP Delivery of RNA Therapeutics
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Savara Inc.
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases....
Ziphius
Diving deeper to uncover the possibilities of self-amplifying RNA.
About ReCode Therapeutics
ReCode Therapeutics, founded in 2015, is leading innovations in the biopharma sector with its focus on genetic medicines. Based in the United States, this clinical-stage company is setting a benchmark in the Biotechnology and Pharmaceutical industries. With the slogan "Powering the next wave of genetic medicines throug...
Targeted Delivery of Genetic Medicines, Development of Rare Disease Therapeutics, SORT Lipid Nanoparticle Platform
Patients with Genetically Defined Diseases, Healthcare Providers, Biotech and Pharmaceutical Partners
Genetic Medicines, MRNA Therapeutics, Gene Correction, Lipid Nanoparticles, Selective Organ Targeting, SORT Platform, Genetic Delivery Systems, Non-Viral Delivery, Cystic Fibrosis, Primary Ciliary Dyskinesia, Genetic Respiratory Diseases, Clinical-Stage Company
B2B, B2D, Platform
Licensing, Project Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ReCode Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ReCode Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.